Sommadossi Jean-Pierre (CIK 1296995) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-03). Recent activity: Buy AVIR (272,983 shares), Sell AVIR (106,093 shares), Buy AVIR (300,000 shares), Buy AVIR (173,467 shares), Buy AVIR (99,517 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | Atea Pharmaceuticals, Inc. (AVIR) | President, CEO, and Chairman | Buy | 272,983 | $0 |
| 2026-02-03 | Atea Pharmaceuticals, Inc. (AVIR) | President, CEO, and Chairman | Sell | 106,093 | $449,834 |
| 2026-02-03 | Atea Pharmaceuticals, Inc. (AVIR) | President, CEO, and Chairman | Buy | 300,000 | $372,000 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | President, CEO, and Chairman | Buy | 173,467 | $0 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | President, CEO, and Chairman | Buy | 99,517 | $0 |
| 2025-02-04 | Atea Pharmaceuticals, Inc. (AVIR) | President, CEO, and Chairman | Sell | 88,601 | $271,119 |
Source: SEC Form 4 filings · as of 2026-02-03